Circulating nucleosomes and severity of illness in children suffering from meningococcal sepsis treated with protein C.

Abstract

OBJECTIVE:

Cell death leading to circulating nucleosomes and histones is a critical step in the pathogenesis of sepsis and contributes to lethality. Activated protein C was demonstrated to attenuate the harmful effects of histones. The objective of this retrospective study was to evaluate whether nucleosomes correlate with the severity of the inflammatory response and mortality in children suffering from severe meningococcal sepsis. Furthermore, we wanted to study the effects of infusion of protein C on nucleosome levels in children with septic purpura.

DESIGN:

Retrospective analysis of nucleosome levels in children suffering from meningococcal sepsis treated with either placebo or protein C.

SETTING:

Pediatric intensive care unit of a tertiary care university center.

PATIENTS:

In a randomized, placebo-controlled study, either protein C or placebo was administered to 38 children suffering from meningococcal sepsis. Nucleosome levels have been measured retrospectively in these 38 children suffering from meningococcal sepsis.

MEASUREMENTS AND MAIN RESULTS:

Twenty-eight children were treated with protein C and 10 received placebo. Nucleosome levels were significantly higher in nonsurvivors (n = 9) at any time point measured as compared to survivors (n = 29). Nucleosome levels significantly correlated with organ dysfunction scores, cytokines, and parameters for coagulation. Patients treated with protein C had significantly higher activated protein C levels than children receiving placebo. We could not find a clear effect of activated protein C on nucleosome levels in these patients.

CONCLUSION:

Circulating nucleosomes correlated with the severity of the inflammatory response and were associated with mortality in children suffering from meningococcal sepsis. We show that protein C administration does not decrease nucleosome levels in these patients.

• Authors: Sacha Zeerleder, Femke Stephan, Marieke Emonts, Ester D de Kleijn, Charles T Esmon, Katalin Varadi, Cornelis Erik Hack, Jan A Hazelzet
• Journal: Critical care medicine (Crit Care Med) Vol. 40 Issue 12 Pg. 3224-9 (Dec 2012) ISSN: 1530-0293 [Electronic] United States
• PMID: 22932399 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)

Chemical References

• Fibrinolytic Agents
• Nucleosomes
• Protein C

Topics

• Adolescent
• Bacteremia (drug therapy, metabolism)
• Child
• Child, Preschool
• Double-Blind Method
• Fibrinolytic Agents (therapeutic use)
• Humans
• Infant
• Intensive Care Units, Pediatric
• Meningococcal Infections (drug therapy, metabolism)
• Netherlands
• Nucleosomes (drug effects, metabolism)
• Protein C (therapeutic use)
• Retrospective Studies
• Sepsis (drug therapy, physiopathology)
• Severity of Illness Index